On November 18, 2024, MIRA Pharmaceuticals underwent significant changes to its Board of Directors. Michael Jerman resigned from his position as a board member and Chair of the Audit Committee, citing a desire to pursue other activities. The company emphasized that Jerman's departure was not due to any disagreement.Effective immediately, Matthew Pratt Whalen, CPA, age 45, was appointed as a new board member and Chairman of the Audit Committee. Whalen brings over two decades of experience in public accounting and corporate finance. He currently serves as a director at Telmoir Pharmaceuticals and as CFO of Power Digital Marketing Inc. Previously, Whalen held the CFO position at MRC Smart Technology Solutions, a Xerox subsidiary.Whalen's appointment is expected to strengthen MIRA's financial oversight. His extensive experience in finance, coupled with his CPA credentials and board experience, positions him as a valuable addition to MIRA Pharmaceuticals' leadership team.

On November 18, 2024, MIRA Pharmaceuticals underwent significant changes to its Board of Directors. Michael Jerman resigned from his position as a board member and Chair of the Audit Committee, citing a desire to pursue other activities. The company emphasized that Jerman's departure was not due to any disagreement.Effective immediately, Matthew Pratt Whalen, CPA, age 45, was appointed as a new board member and Chairman of the Audit Committee. Whalen brings over two decades of experience in public accounting and corporate finance. He currently serves as a director at Telmoir Pharmaceuticals and as CFO of Power Digital Marketing Inc. Previously, Whalen held the CFO position at MRC Smart Technology Solutions, a Xerox subsidiary.Whalen's appointment is expected to strengthen MIRA's financial oversight. His extensive experience in finance, coupled with his CPA credentials and board experience, positions him as a valuable addition to MIRA Pharmaceuticals' leadership team.